Cover Image
市場調查報告書

Advinus Therapeutics Ltd. : 產品平台分析

Advinus Therapeutics Ltd - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 255993
出版日期 內容資訊 英文 42 Pages
訂單完成後即時交付
價格
Back to Top
Advinus Therapeutics Ltd. : 產品平台分析 Advinus Therapeutics Ltd - Product Pipeline Review - 2016
出版日期: 2016年06月22日 內容資訊: 英文 42 Pages
簡介

Advinus Therapeutics Ltd.是Tata Sons Ltd.的子公司,是研究型製藥公司,正在提供藥物研發,醫藥開發還有農業開發服務之製藥,農業,生物科技產業。該公司為了治療代謝障礙和發炎性疾病,神經退化性疾病,也致力於小分子製劑的開發。

本報告提供Advinus Therapeutics Ltd.的治療藥開發平台的現狀及各開發階段比較分析,藥物標的,作用機制,給藥途徑,各分子類型的治療藥的被評估及休止的計劃相關資訊等。

Advinus Therapeutics Ltd.的基本資料

  • Advinus Therapeutics Ltd.概要
  • 主要資訊
  • 企業資料

Advinus Therapeutics Ltd.:R&D概要

  • 主要的治療範圍

Advinus Therapeutics Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Advinus Therapeutics Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第Ⅱ期的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Advinus Therapeutics Ltd.:藥物簡介

Advinus Therapeutics Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Advinus Therapeutics Ltd.:最近的開發平台趨勢

Advinus Therapeutics Ltd.:暫停中的計劃

Advinus Therapeutics Ltd.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08069CDB

Summary

Global Markets Direct's, 'Advinus Therapeutics Ltd - Product Pipeline Review - 2016', provides an overview of the Advinus Therapeutics Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Advinus Therapeutics Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Advinus Therapeutics Ltd
  • The report provides overview of Advinus Therapeutics Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Advinus Therapeutics Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Advinus Therapeutics Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Advinus Therapeutics Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Advinus Therapeutics Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Advinus Therapeutics Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Advinus Therapeutics Ltd Snapshot
    • Advinus Therapeutics Ltd Overview
    • Key Information
    • Key Facts
  • Advinus Therapeutics Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Advinus Therapeutics Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Advinus Therapeutics Ltd - Pipeline Products Glance
    • Advinus Therapeutics Ltd - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Advinus Therapeutics Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Advinus Therapeutics Ltd - Drug Profiles
    • GKM-001
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Type 2 Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PNQ-103
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PNQ-201
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PNQ-370
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PNQ-849
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Visceral Leishmaniasis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit FAAH for Chemotherapy Induced Peripheral Neuropathy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PNQ-154
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PNQ-401
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PNQ-701
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule for Leishmaniasis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Agonize GPR40 and GPR120 Receptors for Type 2 Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Antagonize GPR40 for Obesity
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Antagonize GPR91 for Retinal Angiogenesis and Liver Fibrosis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Antagonize RAR-Related Orphan Receptor Gamma for Psoriasis
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule to Inhibit BTK for Inflammation, Autoimmune Disorders and Cancer
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Advinus Therapeutics Ltd - Pipeline Analysis
    • Advinus Therapeutics Ltd - Pipeline Products by Target
    • Advinus Therapeutics Ltd - Pipeline Products by Route of Administration
    • Advinus Therapeutics Ltd - Pipeline Products by Molecule Type
    • Advinus Therapeutics Ltd - Pipeline Products by Mechanism of Action
  • Advinus Therapeutics Ltd - Recent Pipeline Updates
  • Advinus Therapeutics Ltd - Dormant Projects
  • Advinus Therapeutics Ltd - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Advinus Therapeutics Ltd, Key Information
  • Advinus Therapeutics Ltd, Key Facts
  • Advinus Therapeutics Ltd - Pipeline by Indication, 2016
  • Advinus Therapeutics Ltd - Pipeline by Stage of Development, 2016
  • Advinus Therapeutics Ltd - Monotherapy Products in Pipeline, 2016
  • Advinus Therapeutics Ltd - Partnered Products in Pipeline, 2016
  • Advinus Therapeutics Ltd - Partnered Products/ Combination Treatment Modalities, 2016
  • Advinus Therapeutics Ltd - Phase II, 2016
  • Advinus Therapeutics Ltd - Preclinical, 2016
  • Advinus Therapeutics Ltd - Discovery, 2016
  • Advinus Therapeutics Ltd - Pipeline by Target, 2016
  • Advinus Therapeutics Ltd - Pipeline by Route of Administration, 2016
  • Advinus Therapeutics Ltd - Pipeline by Molecule Type, 2016
  • Advinus Therapeutics Ltd - Pipeline Products by Mechanism of Action, 2016
  • Advinus Therapeutics Ltd - Recent Pipeline Updates, 2016
  • Advinus Therapeutics Ltd - Dormant Developmental Projects,2016
  • Advinus Therapeutics Ltd, Other Locations

List of Figures

  • Advinus Therapeutics Ltd - Pipeline by Top 10 Indication, 2016
  • Advinus Therapeutics Ltd - Pipeline by Stage of Development, 2016
  • Advinus Therapeutics Ltd - Monotherapy Products in Pipeline, 2016
  • Advinus Therapeutics Ltd - Partnered Products in Pipeline, 2016
  • Advinus Therapeutics Ltd - Pipeline by Top 10 Target, 2016
  • Advinus Therapeutics Ltd - Pipeline by Route of Administration, 2016
  • Advinus Therapeutics Ltd - Pipeline by Molecule Type, 2016
  • Advinus Therapeutics Ltd - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top